Ac. Hellin et al., Roles of nuclear factor-kappa B, p53, and p21/WAF1 in daunomycin-induced cell cycle arrest and apoptosis, J PHARM EXP, 295(3), 2000, pp. 870-878
Citations number
41
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Daunomycin is a potent inducer of p53 and NF-kappaB transcription factors.
It is also able to increase the amount of the p21 cyclin-dependent kinase i
nhibitor. The human p21 promoter harbors p53-responsive elements and an NF-
kappaB binding site. We demonstrated, in human breast and colon carcinoma c
ells, the binding of NF-kappaB dimers to the kappaB site and the transcript
ional activation of the human p21 promoter by daunomycin and by NF-kappaB s
ubunits, thereby confirming the functionality of this kappaB binding site.
However, using different tumor cell lines where p53 or NF-kappaB was inacti
ve, we showed that p21 activation and cell cycle arrest induced by daunomyc
in was p53-dependent and NF-kappaB-independent, whereas daunomycin-induced
apoptosis was p53- and NF-kappaB-independent.